Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H30O3 |
Molecular Weight | 330.4611 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4C[C@@H](C)[C@@]23[H]
InChI
InChIKey=IVCRCPJOLWECJU-XQVQQVTHSA-N
InChI=1S/C21H30O3/c1-12-10-14-11-15(23)4-5-16(14)17-8-9-21(3)18(20(12)17)6-7-19(21)24-13(2)22/h11-12,16-20H,4-10H2,1-3H3/t12-,16+,17-,18+,19+,20-,21+/m1/s1
Molecular Formula | C21H30O3 |
Molecular Weight | 330.4611 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Trestolone is a synthetic androgen that inhibits the release of follicle-stimulating hormone and impairs spermatogenesis. Luteinizing hormone is also suppressed, which cuts production of testosterone. The azoospermia and oligospermia are reversible after discontinuation of trestolone. Trestolone has androgenic and anabolic properties and loss of secondary sex characteristics is not seen. Like testosterone, trestolone undergoes enzymatic aromatization to an estrogen. The use of trestolone instead of testosterone for androgen replacement therapy could have health-promoting effects by reducing the occurrence of prostate disease. Trestolone had been in phase II clinical trial for the andropause control. However, this development was discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. | 2003 Mar |
|
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. | 2005 Apr |
|
Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. | 2006 Mar 1 |
|
Steroid hormones for contraception in men. | 2007 Apr 18 |
|
The latest options and future agents for treating male hypogonadism. | 2007 Dec |
|
7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men. | 2007 Sep-Oct |
|
The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects. | 2010 Oct |
|
Effects of synthetic androgens on liver function using the rabbit as a model. | 2010 Sep-Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:09 GMT 2023
by
admin
on
Fri Dec 15 15:16:09 GMT 2023
|
Record UNII |
52XDF4N1XL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C243
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
52XDF4N1XL
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL452329
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
10246085
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
DB13958
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
69948
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
6157-87-5
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
C98255
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
DTXSID80977160
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY | |||
|
Trestolone acetate
Created by
admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |